Vertaling van "patent and will not launch zoledronic " (Nederlands → Frans) :

Teva has dropped the challenge against the Novartis patent and will not launch zoledronic acid in the US until after the Zometa and Reclast patent expires in March 2013.
Teva renonce à contester le brevet de Novartis et ne lancera pas de générique de l’acide zolédronique aux Etats-Unis avant l’expiration de ce brevet en mars 2013.

Since the patent was not held to be invalid at this stage of the litigation, the case will continue to a full trial on its merits.
Le brevet n’étant pas considéré comme non valable à ce state du litige, l’action sera poursuivie dans un procès complet au fond.

Since the patent was not held invalid at this stage of the litigation, the case will continue to a full trial on its merits.
Le brevet n’étant pas considéré comme non valable à ce state du litige, l’action sera poursuivie dans un procès complet au fond.